Establishing reference intervals in the coagulation laboratory

Abstract

Summary Introduction Obtaining a reference interval (RI) is a challenge for any laboratory and becomes more complicated in the coagulation laboratory due to testing on samples with limited stability on reagents that are poorly standardized. Reference intervals are required to be able to evaluate results in relation to a patients’ hemostatic disorder. This becomes one of the most important tasks conducted in the coagulation laboratory. However, many laboratories lack the time, finances and in many cases the expertise to conduct this study. Methods Many RI are obtained from package inserts, or from publications written by experts in lieu of laboratories conducting their own studies. An overview of validating reference intervals and options for verifying or transference of reference intervals is discussed. Results Based on the confidence interval and the acceptability of risk laboratories are willing to accept, coagulation laboratories have options to conduct robust studies for their RI. Data mining or global reference studies may help to provide data for age specific ranges. Conclusions Pre‐analytical variables and selection of healthy subjects have the largest impact on coagulation testing outcomes and need to be well controlled during the establishment of reference intervals. Laboratories have options in lieu of conducting a full validation on how to verify RI based on smaller RI studies or transference of RI after determining compatibility of the original RI study.

Establishing a reference range for thromboelastograph parameters in the neonatal period

“…However, the usefulness of the TEG is limited in paediatric populations, especially neonates, mainly owing to the lack of reference ranges and standardization. Currently, the normal reference range of neonatal TEG parameters is mostly based on the biological reference range of adults provided by reagent manufacturers . Approximately 8.5% of the healthy neonates were diagnosed with coagulation abnormalities according to the reference range provided by the manufacturers for TEG determination .…”

“…Currently, the normal reference range of neonatal TEG parameters is mostly based on the biological reference range of adults provided by reagent manufacturers. 30 Approximately 8.5% of the healthy neonates were diagnosed with coagulation abnormalities according to the reference range provided by the manufacturers for TEG determination. 31 The results may mislead clinicians in the diagnosis and treatment and cause adverse events.…”

Bleeding and bruising in Osteogenesis Imperfecta: International Society on Thrombosis and Haemostasis bleeding assessment tool and haemostasis laboratory assessment in 22 individuals

“…Fibrinolysis was determined by semi‐automated thromboelastometry (ROTEM® delta; Werfen Netherlands, Breda, the Netherlands), which was locally calibrated as per the verification guidelines (Clinical & Laboratory Standards Institute [CLSI], ; Castellone, ; Ozarda et al , ). Clot formation and lysis was determined after addition of reagents activating the internal or external coagulation pathway.…”

Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey

“…It is important that any recommendation about this should have a valid statistical basis . Laboratories need to consider whether they are calculating an in‐house cut‐off value (in which case at least 120 different healthy normal subjects are needed to calculate the 97.5th centile with 95% confidence) or verifying a manufacturer's cut‐off (when 20‐40 normal subjects may be used) . From a statistical point of view, the minimum sample size for a reliable estimation of the 99th centile is at least 300 .…”